In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wk

Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. N Engl J Med. 2023;388:1478-1490. 36877098.

Saved in:
Bibliographic Details
Published inAnnals of internal medicine Vol. 176; no. 6; p. JC69
Main Author Estrada, Rodolfo A
Format Journal Article
LanguageEnglish
Published United States 01.06.2023
Subjects
Antihypertensive Agents - therapeutic use
Drug Therapy, Combination
Humans
Hypertension, Pulmonary - drug therapy
Recombinant Fusion Proteins - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. N Engl J Med. 2023;388:1478-1490. 36877098.
ISSN:1539-3704
DOI:10.7326/J23-0034